What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Leukemia
Brenda M. Sandmaier mainly focuses on Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Surgery and Oncology.
Her Transplantation research is multidisciplinary, incorporating perspectives in Immunosuppression, Immunology, Total body irradiation, Transplantation Conditioning and Fludarabine.
Brenda M. Sandmaier combines topics linked to Gastroenterology with her work on Internal medicine.
Her biological study spans a wide range of topics, including Cumulative incidence, Retrospective cohort study, Myelodysplastic syndromes, Survival analysis and Acute leukemia.
Her work in Surgery tackles topics such as Comorbidity which are related to areas like Cause of death and Clinical trial.
Her research in Oncology intersects with topics in Cancer, Cancer vaccine, Immunotherapy, Stem cell and Lymphoma.
Her most cited work include:
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. (1845 citations)
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. (1845 citations)
- Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects (1264 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Surgery and Oncology.
Her research integrates issues of Immunosuppression, Immunology, Total body irradiation and Fludarabine in her study of Transplantation.
Her Internal medicine research includes themes of Gastroenterology and Hematopoietic cell.
The study incorporates disciplines such as Survival rate, Myeloid, Cumulative incidence, Transplantation Conditioning and Survival analysis in addition to Hematopoietic stem cell transplantation.
Brenda M. Sandmaier has included themes like Urology and Comorbidity in her Surgery study.
The Oncology study combines topics in areas such as Chemotherapy, Minimal residual disease, Myeloid leukemia, Myelodysplastic syndromes and Lymphoma.
She most often published in these fields:
- Transplantation (128.17%)
- Internal medicine (118.19%)
- Hematopoietic stem cell transplantation (69.41%)
What were the highlights of her more recent work (between 2016-2021)?
- Internal medicine (118.19%)
- Transplantation (128.17%)
- Oncology (52.83%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Fludarabine.
Her Internal medicine study frequently draws connections to adjacent fields such as Gastroenterology.
Brenda M. Sandmaier is involved in the study of Transplantation that focuses on Graft-versus-host disease in particular.
Her Oncology research incorporates elements of Complete remission, Chemotherapy, Young adult, Minimal residual disease and Lymphoma.
In her work, Surgery is strongly intertwined with Univariate analysis, which is a subfield of Hematopoietic stem cell transplantation.
Her studies in Fludarabine integrate themes in fields like Radioimmunotherapy, B-cell lymphoma and Sirolimus.
Between 2016 and 2021, her most popular works were:
- The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality. (82 citations)
- The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality. (82 citations)
- Results of a Phase 1 Study of Quizartinib as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Remission Following Allogeneic Hematopoietic Stem Cell Transplant (59 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Leukemia
The scientist’s investigation covers issues in Transplantation, Internal medicine, Oncology, Hematopoietic stem cell transplantation and Hazard ratio.
Brenda M. Sandmaier combines subjects such as Retrospective cohort study, Cumulative incidence, Total body irradiation, Myeloid leukemia and Fludarabine with her study of Transplantation.
Her Internal medicine research incorporates themes from Gastroenterology and Surgery.
She has researched Oncology in several fields, including Hematopoietic cell, Cohort, Young adult, Allogeneic transplantation and Multiple myeloma.
Her Hematopoietic stem cell transplantation research is multidisciplinary, relying on both Antibody and Proportional hazards model.
Her Hazard ratio research incorporates themes from Survival analysis and Immunology, Cord blood.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
